Skip to main content
An official website of the United States government

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Asefa, Mela
mela.asefa@nih.gov
240-276-6422
5E328 Program Support Assistant | Breast and Gynecologic Cancer
Program Support Assistant | Prostate and Urologic Cancer
House, Margaret, RN, B.S.N.
margaret.house@nih.gov
240-276-7047
5E306 Deputy Chief | Prostate and Urologic Cancer
Parnes, Howard L., M.D.
howard.parnes@nih.gov
240-276-7045
5E302 Chief | Prostate and Urologic Cancer

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Livneh, Zvi

Weizmann Institute Of Science
United States

Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort 5U01CA279001-03 Claire Zhu, Ph.D.
Lokshin, Anna E

University Of Pittsburgh At Pittsburgh
United States

Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms 5R01CA247220-05 Christos Patriotis, Ph.D., M.Sc.
Lokshin, Anna E

University Of Pittsburgh At Pittsburgh
United States

Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer 5R01CA254036-05 Matthew Young, Ph.D.
Lowry, Kathryn Paige

University Of Washington
United States

Evaluation of Commercial Mammography-Based Artificial Intelligence Algorithms for Breast Cancer Risk Prediction in U.S. Screening Populations 5R37CA292399-02 Claire Zhu, Ph.D.
Lu, Junxuan

Pennsylvania State Univ Hershey Med Ctr
United States

Early clinial trials for Angelica herbal supplements for prostate cancer interception 4R01CA260901-04 Gabriela Riscuta, M.D., CNS
Lubman, David M.

University Of Michigan At Ann Arbor
United States

Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach 5R01CA160254-14 Matthew Young, Ph.D.
Lyden, David Charles

Weill Medical Coll Of Cornell Univ
United States

Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection 5R01CA218513-08 Matthew Young, Ph.D.
Maclean, Paul S.

University Of Colorado Denver
United States

Novel dietary interventions for reducing obesity-associated breast cancer 5R01CA258766-04 Young Kim, Ph.D.
Madeleine, Margaret M

Fred Hutchinson Cancer Center
United States

Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center 3U54CA242977-07S4 Maria Silvina Frech, Ph.D., M.S.
Mahan, Kristin Eckel

University Of Texas Hlth Sci Ctr Houston
United States

Circadian regulation of astrocytic adenosine kinase in the irradiated and cancer brain 1R21CA292148-01 John Clifford, Ph.D.
Maitra, Anirban

New York University School Of Medicine
United States

Clinical Validation Center for Early Detection of Pancreatic Cancer 7U01CA200468-09 Matthew Young, Ph.D.
Majumder, Shounak

Mayo Clinic Rochester
United States

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer 5U01CA210138-09 Matthew Young, Ph.D.
Maldonado, Fabien

Vanderbilt University Medical Center
United States

Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures 5R01CA253923-05
Mallery, Susan R

Ohio State University
United States

Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions 5R01CA227273-06 Malgorzata Wojtowicz, M.D.
Mallery, Susan R

Ohio State University
United States

Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention 5R01CA258757-04 Malgorzata Wojtowicz, M.D.